Diabetes: ($13 Billion) Oral Insulin
Unique in a competitive space
Orally delivered, chemically unaltered human insulin
Continued growth of diabetic population: Drug market for Type 2 diabetes estimated to reach $20 Billion in 2010*
Source: Natexis Bleichroeder, “Diabetes is set for major innovation”, 9/03